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ABSTRACT. Lanthanide ions have been successfully used as luminescent probes in several biological systems.
The terbium (Tb) luminescence is greatly enhanced in Tb(III)-protein systems by non-radiative energy transfer
from aromatic chromophores to bound Tb3+ ions. In this study, the luminescent properties of terbium have
been used to monitor the metal-peptide interactions of angiotensin II, a linear octopeptide hormone (Asp-Arg-
Val-Tyr-Ile-His-Pro-Phe). The terbium luminescence was enhanced when the metal-complex was excited at
either 259 nm or 280 nm (Phe and Tyr absorption bands, respectively). The results from a series of experi-
ments with amino acids and small peptides show that the terbium luminescence from the Tb-Ang II complex
is about the same as observed for a Tb-Phe complex when excited at 259 nm, but only 34% of the value of
a Tb-Tyr complex excited at 280 nm. These results confirm the structural model of angiotensin II and show
that the low enhancement of the terbium luminescence in peptide and amino acid complexes is due to weak
binding and not poor energy transfer.
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INTRODUCTION
Angiotensin II (Ang II) is a linear octoapeptide
hormone (Asp ' -Arg ' -Val ' -TyrMle ' -His ' -Pro 7 -
Phe8) which elicits physiologic responses in target tis-
sues by initially interacting with a membrane receptor.
Metal ions have been shown to enhance the biologi-
cal activity and receptor binding of the hormone. Re-
cent results suggest that metal ions induce con-
formational changes in the hormone which produce a
more physiologically active conformer (Schaechtelin et al.
1974). Consequently, many conformational-structure-
function (for reviews see Marshall et al. 1974, Regoli et
al. 1974, Peach 1977) and metal ion (Na+ and Ca2 + ,
Schaechtelin et al. 1974, Schaechtelin et al. 1975, Blanc
et al. 1978, Gunther et al. 1980; lanthanide ions,
Lenkinski et al. 1978, Canada 1981, Lenkinski and
Stephens 1981, Lenkinski and Stephens 1983) studies
have been reported.
Lanthanide ions, especially terbium (Tb3+) and euro-
pium (Eu3+), have been used as luminescent probes in
calcium-binding protein (Martin 1983) to determine cal-
cium and lanthanide elements in dilute solution (Miller
and Senkfor 1982), and to develop an immunoassay for
gentamicin (Wilmott et al. 1984). In these cases, the
emission from Tb shows an enhancement factor of up
to 105 when compared to the luminescence from free
aqueous terbium. Lanthanide luminescence results from
intraconfigurational f-f transitions. In aqueous solution,
the lanthanide luminescence is of moderate strength even
with high concentrations because the molar absorptivities
are low. Water also quenches the emission. However,
when the lanthanide ions are bound to proteins and
certain other ligands they may be excited indirectly.
The ions receive energy by radiationless energy transfer
from an efficient donor, such as an excited aromatic
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chromophore. The ligands with aromatic chromophores
also provide a more hydrophobic environment which
reduces the quenching. Both of these factors contri-
bute to the enormous enhancement of the lanthanide
emission.
In this study, the luminescent properties of terbium
have been used to monitor the metal-peptide interactions
of angiotensin II. The luminescent properties of amino
acid and small peptide complexes with terbium were also
examined.
METHODS AND MATERIALS
Angiotensin II was purchased from Sigma Chemical Co; Amino
acids and small peptides were obtained from Sigma and United States
Biochemical Corp. All were used without purification. Angiotensin II
(Ang II) solutions were made with 0.05 M HEPES buffer at pH 7.4;
the amino acids and small peptide solutions were prepared in 0.01 M
piperazine buffer at pH 6.5. High pH studies were not possible due
to the limited solubility of Tb3+ in basic media. Terbium solu-
tions were prepared with TbCl3 • 6H2O(99-9%) obtained from Alfa
Inorganics.
The concentrations of Ang II samples were determined from
tyrosine ultraviolet absorption at 275 nm with a Cary 219 spec-
trophotometer by Varian. All of the luminescence measurements were
made with an Aminco-Bowman Ratio II spectrofluorometer at room
temperature using standard 1-cm2 quartz cells.
For the titration experiment, 2.0 mL of the Ang II solution was
placed in the fluorescence cell. The relative intensity was recorded
after microliter aliquots of Tb3+ were added to the sample cell.
RESULTS AND DISCUSSION
When excited, terbium ions phosphoresce, producing
a characteristic green emission. The phosphorescence
spectrum is composed of four narrow bands from 450 to
650 nm. The most intense band (Amax545 nm) is due
to a D4 > F5 transition. Upon direct excitation, the
most intense band in the excitation spectrum is at
260 nm, when the pH is low. However, the excitation
spectrum is pH dependent, as shown in Figure 1 for a
23 mM solution of Tb3+. The solution at pH 8.4 was
cloudy; at pH 10, the Tb3+ was extensively precipitated
as the hydroxide. The shift in the excitation spectrum
coincides with hydroxy complex formation of Tb with
water which occurs at pH 7 (Prados et al. 1974).
When Tb3+ is added to a solution of Ang II, the native
tyrosine fluorescence is quenched, whereas the terbium
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FIGURE 1. Effect of pH on the terbium excitation spectrum (emis-
sion at 545 nm). pH: (a) 6.5, (b) 7.4, (c) 8.4, (d) 10. Relative
intensity shown in arbitrary units.
luminescence is enhanced. The excitation spectrum of a
solution with 2.7 mM terbium is compared with the
excitation spectrum of a solution with 2.7 mM terbium
and 61 /xm Ang II in Figure 2. The terbium emission
is enhanced in the presence of Ang II. The effects of
added increments of Tb3 + at pH 7.4 on the relative emis-
sion intensity at 545 nm, when Ang II is irradiated at
280 nm, is shown in Figure 3.
The enhancement (E) of the terbium luminescence at
545 nm is defined as:
where: Io is the relative intensity without
the ligand present in solution.
The enhancement values calculated from Figure 2 are
shown in Table 1. Values are reported for both tyrosine
(280 nm) and phenylalanine (259 nm) excitation. The
value at 280 nm is smaller than the value reported earlier
(Canada 1981). The enhancement is calculated on a molar
basis; the concentration of the Tb-Ang II complex in
solution was determined from the dissociation constants
for the carboxylates of Asp1 and Phe (Lenkinski and
Stephens 1983).
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FIGURE 2. Excitation spectra of 2.7 mM terbium (a) and 2.7 mM
terbium with 61 /JLM Ang. II. Emission at 545 nm and pH 7.4.
Lanthanide complexes of amino acids have been syn-
thesized and characterized (Misra et al. 1982) and studied
by polarography (Pitre and Chitale 1981), luminescence
(Bel'tyukova et al. 1979), titration, and circular dichro-
ism spectroscopy (Prados et al. 1974). Lanthanide ions
coordinate the carboxylate group of the amino acids with
the ammonium group remaining protonated (pK > 9)
and unbound. The zwitterion forms innersphere, mono-
dentate complexes with trivalent lanthanide ions.
The terbium luminescence is enhanced when certain
amino acids and small peptides are added to the solution.
TABLE 1
Relative Intensity of Terbium Luminescence in
Complexes with Amino Acids and Peptides
Ligand*
Tyr
acetyl-Tyr
Gly-Tyr
Gly-Gly-Tyr
Phe
acetyl-Phe
Ala
Trp
acetyl-Trp
Leu
Ang II
Concentration M
5.0 X IO"4
7.0 X IO"4
5.9 X IO"4
5.0 X IO"4
5.0 X IO"4
5.8 x 1O~4
5.0 X IO"4
5.0 X IO"4
4.9 x io"4
5.0 x IO"4
6.1 x IO"5
Enhancement**
4.7 X 10'
9.7 X 10'
3.3 X 10'
3.2 X 10'
23
35
0
- 8 9
2.3 X 10'
0
1.6 X 102 (280 nm)
45 (259 nm)
23 mM Tb (III) and pH 6.5 for all ligands except Ang II which
had 2.7 mM Tb (III) and pH 7.4. L-amino acids were used.
*The average formation constant for Eu-Gly and Nd-Ala complexes
was used to estimate the concentration of the bound ligand (Tanner
and Choppin 1968, Sherry et al. 1973) for the amino acids and
small peptides.
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FIGURE 3. Titration of buffer (a) and 61 ;u,M Ang II (b) with terbium excitation at 280 nm, emission
at 545 nm and pH 7.4.
Figure 4 illustrates the enhancement for L-tyrosine and
n-acetyl-L-tyrosine. The enhancement values are sum-
marized in Table 1. The values reported in Table 1 are
different than the values reported earlier (Bel'tyukova
et al. 1979). Bel'tyukova et al. (1979) used a Tb3" con-
centration that was five times greater than that used in
our study, and the complexes were subjected to high pH
conditions (pH range 7-9). Below pH 7.4, all of our
solutions were optically clear. They became cloudy, how-
ever, as the pH approached 8, even when a large excess
of amino acid was present.
Since the carboxylate group of the zwitterionic amino
acids only coordinates weakly to lanthanide ions, meth-
ods to increase the binding and terbium luminescence
were investigated. First, excess ligand was added to shift
the position of equilibrium. However, strong inner filter
effects were observed (Martin 1983, pp. 260-264). The
use of excess Tb provided better experimental condi-
tions. Second, the positive charge associated with the
ammonium group was removed from the vicinity of the
carboxylate group by peptide bond formation and acety-
lation. For Gly-Tyr and Gly-Gly-Tyr there was no major
change in the enhancement value when compared with
the value for Tyr, but the value for acetyl-Tyr increased
by a factor of two. The Trp quenched the terbium emis-
sion (negative enhancement value), whereas acetyl-Trp
gave an enhancement. The observed increase upon
actylation is presumably due to a larger formation con-
stant. Attempts to acetylate Ang II in solution were
unsuccessful because the excess acetate quenched the
terbium luminescence.
Finally, the amino acid results may be used to evaluate
the Ang II results. Since experimental results suggest
that a Forster dipole-dipole mechanism with an r~6
dependence between donor and acceptor metal ion can
be used in these systems, Canada (1981) concluded
that the low value of 3 X 10 for the enhancement of the
Tb-Ang II complex at 280 nm reflects a longer distance
between the bound Tb3 + and the aromatic side chain of
Tyr. Our results show that the distance factor is impor-
tant but cannot be used to explain the small enhancement
factor for the Tb-Ang II complex. When compared to the
amino acid data, the enhancement at 259 nm (Phe
excitation) is about the same as Phe. In both cases, the
carboxylate group of Phe binds directly to the Tb3 + .
However, the enhancement at 280 nm (Tyr excitation) is
only 34% (our value) and 64% (value from Canada 1981)
of the value observed for Tyr. The reduction in the
enhancement for the Ang II complex is clearly related
to the increase in distance between the Tyr4 donor and
Tb3 + acceptor. However, the distance factor doesn't
account for the large difference in enhancement between
the Ang II and protein complexes.
From the data presented in Table 1 and equilibrium
constants [Kd(Asp1-COO") = 1 1 . 4 mM and Kd(Phe8-
COO~) = 2.8 mM] from mmr studies (Lenkinski and
Stephens 1983), we conclude that the low enhancement
of the terbium luminescence in Ang II is due to weak
binding. The monodentate complexes of Ang II, small
peptides, and amino acids do not provide the highly
hydrophobic environment found in proteins. Brittian
(1980) has investigated the circularly polarized lumines-
cence spectra of mixed amino acid complexes. If the amino
acids in these mixed complexes could be selectively
excited, a larger enhancement should be observed.
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FIGURE 4. Excitation spectra of 23 mM terbium (a), 23 mM ter-
bium with 500 /JLM tyr (b) and with 700 M acetyl-tyr (c). Emission
at 545 nm and pH 6.5. Relative intensity shown in arbitrary units.
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